Combined Immunosuppressive Therapy for Severe Graves Dermopathy

Ann Intern Med. 2021 Oct;174(10):1478-1480. doi: 10.7326/L21-0152. Epub 2021 Jun 22.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Acute Disease
  • Cyclophosphamide / administration & dosage
  • Cyclophosphamide / therapeutic use*
  • Dexamethasone / administration & dosage
  • Dexamethasone / therapeutic use*
  • Drug Administration Schedule
  • Drug Therapy, Combination
  • Graves Disease / complications
  • Graves Disease / drug therapy*
  • Humans
  • Immunosuppressive Agents / administration & dosage
  • Immunosuppressive Agents / therapeutic use*
  • Male
  • Middle Aged
  • Myxedema / drug therapy*
  • Myxedema / etiology
  • Rituximab / administration & dosage
  • Rituximab / therapeutic use*

Substances

  • Immunosuppressive Agents
  • Rituximab
  • Dexamethasone
  • Cyclophosphamide